KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NovoCure (NVCR) Raw Materials (2016 - 2019)

NovoCure's Raw Materials history spans 6 years, with the latest figure at $3.4 million for Q2 2019.

  • On a quarterly basis, Raw Materials rose 36.2% to $3.4 million in Q2 2019 year-over-year; TTM through Jun 2019 was $3.4 million, a 36.2% increase, with the full-year FY2018 number at $870000.0, down 79.65% from a year prior.
  • Raw Materials hit $3.4 million in Q2 2019 for NovoCure, up from $1.5 million in the prior quarter.
  • Over the last five years, Raw Materials for NVCR hit a ceiling of $5.9 million in Q3 2017 and a floor of $870000.0 in Q4 2018.
  • Historically, Raw Materials has averaged $3.6 million across 5 years, with a median of $3.6 million in 2015.
  • Biggest five-year swings in Raw Materials: surged 568.82% in 2015 and later tumbled 79.65% in 2018.
  • Tracing NVCR's Raw Materials over 5 years: stood at $3.5 million in 2015, then surged by 49.03% to $5.2 million in 2016, then fell by 18.44% to $4.3 million in 2017, then tumbled by 79.65% to $870000.0 in 2018, then surged by 294.37% to $3.4 million in 2019.
  • Business Quant data shows Raw Materials for NVCR at $3.4 million in Q2 2019, $1.5 million in Q1 2019, and $870000.0 in Q4 2018.